Many patients do well long-term at 5 to 10 mg tirzepatide or 1.0 to 1.7 mg semaglutide
A healthier, more energetic life might be much closer than you realize
For years, glucagon receptor antagonists have been favored as a treatment for both type 1 diabetes and type 2 diabetes, consistent with the idea that hepatic glucagon elevates glycemia, so blocking its effect could lower glycemia and improve glucose control
A healthcare professional can track progress and adjust the dose if needed
The primary mechanisms of action include: Enhancing insulin secretion from pancreatic beta cells in a glucose-dependent manner, which helps lower blood glucose levels without causing excessive hypoglycaemia Suppressing glucagon release from pancreatic alpha cells, reducing hepatic glucose production Slowing gastric emptying , which prolongs the feeling of fullness after meals Acting on appetite centres in the brain , particularly the hypothalamus, to reduce hunger and food intake Most GLP-1 receptor agonists are administered via subcutaneous injection, with dosing frequencies ranging from once daily to once weekly depending on the specific formulation
In contrast, in tandem with dietary and physical activity advice, the placebo resulted in only 3.2% and 27.5 point reductions in placebo cohort members
.webp)
